Vivozon Pharmaceutical Co., Ltd. (KOSDAQ:082800)

South Korea · Delayed Price · Currency is KRW

2,995.00

+125.00 (4.36%)

At close: Aug 14, 2026

-60.12% (1Y)

Market Cap	180.19B -51.6%
Revenue (ttm)	54.86B -36.5%
Net Income	-34.21B
EPS	-682.32
Shares Out	60.16M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	336,298
Open	2,880.00
Previous Close	2,870.00
Day's Range	2,870.00 - 3,500.00
52-Week Range	2,070.00 - 8,470.00
Beta	-0.51
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 21, 2026

About Vivozon Pharmaceutical

Vivozon Pharmaceutical Co., Ltd. researches, develops, produces, and sells LED products primarily in South Korea. The company offers LED packages for interior, general, indoor, decorative, and automotive lighting, as well as display applications. It also provides LED set linear lamps for offices, houses, apartments, buildings, factories, and parking lots. In addition, the company operates Echo House, a lighting show room that sells LED florescent lamps. The company was formerly known as Vivozon Healthcare, Inc. and changed its name to Vivozon P... [Read more]

Industry Pharmaceutical Preparations

Founded 2002

Employees 309

Stock Exchange KOSDAQ

Ticker Symbol 082800

Full Company Profile

Financial Performance

In 2025, Vivozon Pharmaceutical's revenue was 59.34 billion, a decrease of -32.26% compared to the previous year's 87.60 billion. Losses were -32.42 billion, 224.8% more than in 2024.

Financial Statements